Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

come of $0.4 million for the second quarter of 2008. The decrease was primarily attributable to lower dividend and interest income from lower cash, cash equivalent and investment balances.

Other expense, net, increased $35.9 million primarily as a result of a non-cash charge relating to the mark-to-market valuation adjustment to our warrant liability during the second quarter of 2009.

Our income tax benefit decreased $1.6 million to zero for the second quarter of 2009, as we no longer have the ability to carry back losses to previous years to recover taxes paid and it is uncertain that we will be able to utilize these net operating losses against future income. The 2008 income tax benefit reflects the tax effects of the carry back of our 2008 net operating losses to the 2006 tax year to recover 2006 income taxes paid.

Financial Results of Operations for the Six Months Ended June 30, 2009

Total revenues for the first six months of 2009 were $1.8 million compared with $1.5 million for the same period of 2008, an increase of $0.3 million. The increase was primarily the result of higher sales of oxandrolone, due to increased market share achieved by our authorized generic distributor.

Cost of goods sold for the first six months of 2009 were $0.9 million compared with $0.6 million for the same period of 2008, an increase of $0.3 million. The increase in cost of goods sold resulted primarily from higher gross sales of oxandrolone.

Research and development expenses for the first six months of 2009 were $24.4 million, compared with $26.9 million for the same period of 2008, a decrease of $2.5 million. The decrease was primarily due to lower technology transfer expenses of $2.4 million as we near the completion of the technology transfer related to developing our secondary source supplier of pegloticase API. In addition, manufacturing capacity reservation
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a ... producing and marketing of a series of induction heating ... new series of induction brazing equipments . , ... induction brazing refers to the joining of two ... heat. The manager says that there are fundamental differences ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, iFitDress.com, the ... for women, has announced its new selection of black ... are on sale now; they are available at discounted prices, ... says, “The promotion will last for three weeks only. You ... market. Those who are interested in our new items can ...
(Date:12/25/2014)... BellasDress has launched its Christmas Sale, offering ... chosen their best-selling lace wedding dresses, vintage bridesmaid dresses ... , Now, BellasDress.com features popular women’s dresses, and ... prices. The business hopes everyone can have a memorable ... “All our elegant products are made with exquisite materials; ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... Aaron Margolin, professor of microbiology at the University of ... Disease Laboratory, is available to discuss the science and// ... also known as Norwalk and Norwalk-like viruses, are estimated ... the United States each year. Symptoms include vomiting, diarrhea, ...
... salt-laden foods. The campaign group - Consensus Action on Salt ... excess salt out of food stuff. ,The ... shun salty foods, which will in turn encourage manufacturers to ... avoid buying products which contain either more than 1.25g of ...
... nose, during winter is extremely common. Most people are down ... advice certain protective tips which could// help reduce the number ... and flu viruses are transmitted after contact with an infected ... In the context, they advice, that it is imperative ...
... can travel inside your body, can find if you have ... ,After being swallowed, the robot passes through the ... miniature video camera fitted with the device can capture around ... by Alex Zivanovic of Imperial College, London, and other researchers, ...
... first glance, it is difficult to believe anyone would willingly get ... every year to benefit their health//, and these warm baths have ... sought out the brownish-black mud in Bad Wilsnack in Brandenburg for ... Today, it is also available to those who simply want to ...
... keep the price of a cancer drug affordable for ... asked Swiss pharmaceutical major Novartis// to withdraw its case ... to its anti-cancer medicine. ,"India produces affordable ... in many other developing countries. A patent grant to ...
Cached Medicine News:Health News:Sanitation and Science Prevent Norovirus Spread 2Health News:Germany's Therapeutic Mud Baths Have Healing Qualities 2Health News:Drop Patent Petition, Activists Ask Novartis 2
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 /PRNewswire/ ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... shares of its common stock and Series C ... stock.  Funds under the management of QVT Financial ...
(Date:12/24/2014)... Wis. , Dec. 23, 2014 PuraMed ... marketer of over-the-counter (OTC) medicinal and healthcare products, announced ... of MigraPure® H, a hemp-based, advanced headache relief product, ... dispensaries in Colorado , ... . With the MigraPure H Advanced headache ...
(Date:12/24/2014)... 23, 2014  Advanced Medical Isotope Corporation ("AMIC") ... in the development of brachytherapy devices and medical ... that it has filed a de novo ... ("FDA") for marketing clearance for its patented Y-90 ... U.S. Food, Drug and Cosmetic Act (the "Act").  ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to ... switching to Google Apps, will be able to expand and ... help its employees communicate efficiently.  Solos will now have the ... connected computer or mobile device, helping the Company reduce its ...
... Community Pharmacists Association (NCPA) CEO, B. Douglas Hoey, ... the Preserve Community Pharmacy Access NOW! ... culminating an advocacy push that brought community pharmacists to ... Federal Trade Commission (FTC) to reject the proposed mega-merger ...
Cached Medicine Technology:Solos Endoscopy Goes Google 2Solos Endoscopy Goes Google 3Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol 2Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol 3
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
... to seal the arterial puncture site. Duett is ... arteriotomy and the tissue tract with a flowable ... balloon catheter and procoagulant - the Duett sealing ... the bleeding. The Duett is unique in its ...
Medicine Products: